title: Digital pathology in drug discovery and development: multisite integration.
abstract: Digital pathology is an emerging technology that provides an image-based environment for managing and interpreting the information generated from a digitized glass slide, offering substantial improvements in pharmaceutical drug development across discovery, preclinical GLP pathology and oncology clinical trials. Digital pathology is transforming global pharmaceutical research by enabling data sharing to integrate dispersed pharma pathology labs around the world. This article reviews the stages of multisite digital pathology integration in large pharmaceutical companies, offering suggestions for success and highlighting challenges.
authors: Aperio Technologies, Inc., Vista, CA 92081, United States. spotts@aperio.com
authors: Steven J
authors: SJ
authors: Potts
mesh_terms: D022126:Access to Information; D000818:Animals; D003299:Cooperative Behavior; D055808:Drug Discovery; D004345:Drug Industry; D006801:Humans; D007090:Image Interpretation, Computer-Assisted; D016247:Information Storage and Retrieval; D007391:International Cooperation; D010338:Pathology, Clinical / Q000295:instrumentation / Q000379:methods; D010341:Pathology, Veterinary / Q000295:instrumentation / Q000379:methods; D012984:Software; D018511:Systems Integration; D019113:Telepathology / Q000295:instrumentation / Q000379:methods